STOCK MARKET BSE NSE

Serum Institute, Bharat Biotech cut COVID vaccine prices for private hospitals to Rs 225

The Union Health Ministry on Friday announced that those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose.

Published: 09th April 2022 04:25 PM  |   Last Updated: 09th April 2022 04:34 PM   |  A+A-

Covishield and Covaxin (Image for Representational Purpose)

By PTI

NEW DELHI: Vaccine majors Serum Institute of India (SII) and Bharat Biotech on Saturday said they have decided to cut prices of the precaution dose of their respective COVID-19 vaccines to Rs 225 per shot for private hospitals after discussions with the government.

"We are pleased to announce that after discussion with the central government, SII has decided to revise the price of COVISHIELD vaccine for private hospitals from Rs 600 to Rs 225 per dose," SII CEO Adar Poonawalla said in a tweet.

On Friday, the company had said that the precaution dose of its Covishield vaccine against COVID-19 will be priced at Rs 600 per shot for eligible individuals.

Bharat Biotech Co-Founder Joint Managing Director Suchitra Ella in a tweet said: "We welcome the decision to make available precautionary dose for all adults. In consultation with the Central Government, we have decided to revise the price of #COVAXIN from Rs 1,200 to Rs 225 per dose, for #privatehospitals."

SII and Bharat Biotech have been major suppliers of COVID-19 vaccines to the government so far.

The Union Health Ministry on Friday announced that those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose.

According to the health ministry, so far, about 96 per cent of all those above the age of 15 years in India have received at least one vaccine dose, while about 83 per cent have received both doses.

More than 2.4 crore precaution doses have also been administered to healthcare workers, frontline workers and those aged above 60 years.

Besides, 45 per cent of beneficiaries in the 12-14 years age group have received the first dose, the ministry said.

The ongoing free COVID-19 inoculation programme through government vaccination centres for the first and the second dose to the eligible population as well as the precaution dose to healthcare workers, frontline workers and those above 60 years will be accelerated, the ministry stated.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp